A recent survey has found that individuals taking weight loss medications such as Ozempic and Wegovy are significantly increasing their spending on clothing and beauty products. The study, conducted by the consumer research firm NPD Group, indicates that nearly 40% of users have purchased new clothes in smaller sizes, while 30% have invested more in skincare and cosmetics.
Survey Reveals Spending Shifts
The survey, which polled 2,000 adults in the United States, highlights a notable shift in consumer behavior among those using GLP-1 receptor agonists. According to the NPD Group, 35% of respondents reported spending more on clothing, and 28% increased their beauty product expenditure. “These medications are not just changing waistlines; they are reshaping entire spending patterns,” said Marshal Cohen, chief retail analyst at NPD Group.
Impact on Retail Sectors
This trend is already influencing the retail industry. Clothing retailers are seeing a surge in demand for smaller sizes, while beauty brands are marketing products to address skin changes associated with rapid weight loss. The survey also found that 22% of users have purchased new accessories, such as belts and jewelry, to complement their altered body shapes.
Psychological Drivers
Experts attribute the increased spending to both physical necessity and psychological factors. “Many patients feel a renewed sense of confidence and want to reflect that in their appearance,” said Dr. Sarah Johnson, a psychologist specializing in body image. “They also need practical adjustments to their wardrobe as their body changes.”
Broader Economic Implications
The findings suggest that the growing popularity of weight loss medications could have lasting effects on consumer markets. With millions of people now taking these drugs, the demand for clothing and beauty products is expected to continue rising. Retailers are advised to adapt their inventory and marketing strategies to cater to this demographic.
